药物功能重新绘制:瘤免疫治疗的新希望
Jiayi Dong1,2,3, Ting Su1,2,3,4, Jiexiong Wu4
1Department of Immuno-Oncology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangdong Pharmaceutical University, Guangzhou, China.
Frontiers in oncology
|March 31, 2025
概括
将传统药物重新用于癌症免疫疗法提供了一个具有成本效益的策略,以克服治疗耐药性并缩短开发时间表. 这种方法利用了针对新型抗癌应用的既定安全性.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 开发新的抗癌药物是昂贵和耗时的,对副作用的数据有限.
- 传统药物在长期使用后具有成熟的安全性.
- 对免疫检查点抑制剂 (ICI) 的耐药性是癌症免疫治疗中的一个主要挑战.
研究的目的:
- 审查传统药物在瘤免疫治疗中的新应用.
- 探索药物重定向如何提高治疗疗效和克服ICI耐药性.
- 突出重定向药物在扩大癌症治疗选择中的潜力.
主要方法:
- 对癌症免疫治疗中药物重新定位的最新进展的审查.
- 分析用于识别重用药物候选物的系统方法,包括高通量选和计算方法.
- 在瘤免疫治疗中检查特定药物类别 (抗糖尿病,抗高血压,减肥,抗真菌,抗病毒).
主要成果:
- 药物再利用为瘤学新药开发提供了一个经济和可行的战略.
- 重定位传统药物可以通过调节免疫细胞活动或瘤微环境来提高瘤免疫疗法的有效性.
- 确定了具有增强瘤免疫治疗潜力的特定药物类别.
结论:
- 药物重新定位为识别新型癌症治疗方法提供了一个快速且具有成本效益的途径.
- 利用现有的药物安全数据加速了临床翻译.
- 进一步探索重定向药物对于推进癌症免疫疗法和克服耐药性至关重要.
相关概念视频
01:27Tumor Immunotherapy
432
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
432
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K